Match tier
Listed
Presence
Current · Arkansas
Last published
2021
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
A
Azure L. Yarbrough
Researcher
Also affiliated: Arkansas Department of Agriculture (2019–2021)
Faculty Researcher
5 h-index
13 pubs
105 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Azure L. Yarbrough's research focuses on the characterization of cannabinoid receptors as potential therapeutic targets, particularly in the context of Ewing sarcoma. Recent publications investigate how natural and synthetic cannabinoids affect the viability of Ewing sarcoma cells, suggesting a mechanism involving non-canonical CB receptors. This work also explores these receptors as potential targets for anti-cancer drug development.
Yarbrough's scholarship metrics include an h-index of 5, with 13 total publications and 105 total citations. Yarbrough has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Alicja Urbaniak, Paul L. Prather, Amal Shoeib, and Anna Radomińska‐Pandya, with whom Yarbrough shares two publications each.
Metrics
- h-index: 5
- Publications: 13
- Citations: 105
Selected Publications
-
Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development (2021)
-
Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors (2021)
-
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity (2020)
-
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid <i>N</i>‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1<i>H</i>‐indole‐3‐carboxamide (STS‐135) (2020)
-
Oxidative Metabolism and Comparative Analysis of Synthetic Cannabinoid N‐(1‐adamantyl)‐1‐(5‐fluoropentyl)indazole‐3‐carboxamide (5F‐AKB‐48) and the Unfluorinated Analog AKB‐48 (2019)
-
Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22) (2019)
-
Oxidative metabolism of synthetic cannabinoid STS-135 by recombinant P450S and human liver microsomes (2019)
-
Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC (2018)
-
The Effect of Overexpressed DdRabS on Development, Cell Death, Vesicular Trafficking, and the Secretion of Lysosomal Glycosidase Enzymes (2018)
-
Role of inositol polyphosphates in programed cell death in Dictyostelium discoideum and its developmental life cycle (2018)
-
Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants (2018)
-
Identification of Novel Variants of the CB <sub>1</sub> Cannabinoid Receptor in Cancer Cells (2017)
-
Dictyostelium discoideum RabS and Rab2 colocalize with the Golgi and contractile vacuole system and regulate osmoregulation (2016)
Collaboration Network
Top Collaborators
Amal Shoeib
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lori L. Hensley
Jacksonville State University (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Benjamin M. Ford
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lirit N. Franks
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Alicja Urbaniak
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Paul L. Prather
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Karol Kacprzak
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lance Benson
University of Arkansas for Medical Sciences (US)
1 shared publication
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Shengyu Mu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Similar Researchers
Based on overlapping research topics
Lirit N. Franks
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Amal Shoeib
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Hui‐Ming Chang
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Cancer-related molecular mechanisms research
Noemi Garcia Garcia
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Pharmacological Effects and Toxicity Studies
Paul L. Prather
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Alicja Urbaniak
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies